A study assessing efficacy of onabotulinum toxin A in patients with chronic migraine receiving treatment according to the PREEMPT protocol.
Phase of Trial: Phase IV
Latest Information Update: 31 Mar 2017
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 31 Mar 2017 New trial record